Clinical Trials & Research
Search Clinical Trials
Clinical Trials
New Search
| Title | A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer With = 1 CM Residual Invasive Cancer or Positive Lymph Nodes (ypN+) After Neoadjuvant Chemotherapy |
|---|---|
| Disease/Condition | Breast Cancer,Women`s Health,Oncology (Medical/Hematologic),Carcinoma,Neoplasms |
| Description | |
| Eligibility Criteria | Click here for eligibility requirements |
| Principal Investigator | Jesus Anampa Mesias, MD |
| Contact Name | Amanda Erakky |
| Contact Email | aerakky@montefiore.org |
| Protocol Number | 2018-9832 |
| Inclusion/Notes | This Information was obtained from ClinicalTrials.gov |
| Status | Active/Enrolling |
| Adult Clinical Trial | Yes |
| Pediatric Clinical Trial | No |
| Sub-Specialty | Medical and Hematologic Oncology - Breast |
| Adult, Pediatric, Both | Adult |
